Amryt Pharma Holdings Ltd
LSE:AMYT

Watchlist Manager
Amryt Pharma Holdings Ltd Logo
Amryt Pharma Holdings Ltd
LSE:AMYT
Watchlist
Price: 143 GBX -11.73% Market Closed
Market Cap: 457.1m GBX
Have any thoughts about
Amryt Pharma Holdings Ltd?
Write Note

Gross Margin
Amryt Pharma Holdings Ltd

49.2%
Current
41.4%
Average
48.3%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
49.2%
=
Gross Profit
103.4m
/
Revenue
210.2m

Gross Margin Across Competitors

Country UK
Market Cap 453.2m GBP
Gross Margin
49%
Country JP
Market Cap 776 550.9T JPY
Gross Margin
-3%
Country US
Market Cap 789.8B USD
Gross Margin
81%
Country UK
Market Cap 440.4B GBP
Gross Margin
56%
Country DK
Market Cap 3.3T DKK
Gross Margin
85%
Country US
Market Cap 374.3B USD
Gross Margin
69%
Country US
Market Cap 261B USD
Gross Margin
78%
Country CH
Market Cap 209.8B CHF
Gross Margin
73%
Country CH
Market Cap 181.7B CHF
Gross Margin
75%
Country UK
Market Cap 153.5B GBP
Gross Margin
82%
Country IE
Market Cap 154.4B USD
Gross Margin
68%

Profitability Report

View the profitability report to see the full profitability analysis for Amryt Pharma Holdings Ltd.

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
49.2%
=
Gross Profit
103.4m
/
Revenue
210.2m
What is the Gross Margin of Amryt Pharma Holdings Ltd?

Based on Amryt Pharma Holdings Ltd's most recent financial statements, the company has Gross Margin of 49.2%.